PlainRecalls
FDA Devices Moderate Class II Terminated

MicroScan Pos Combo Panel Type 43, Catalog number B1017-217for use in determining antimicrobial agent susceptibility and/or identification to the species level of rapidly growing aerobic and facultative gram-positive cocci, some fastidious aerobic gram-positive cocci and Listeria monocytogenes.

Reported: August 8, 2018 Initiated: May 4, 2018 #Z-2599-2018

Product Description

MicroScan Pos Combo Panel Type 43, Catalog number B1017-217for use in determining antimicrobial agent susceptibility and/or identification to the species level of rapidly growing aerobic and facultative gram-positive cocci, some fastidious aerobic gram-positive cocci and Listeria monocytogenes.

Reason for Recall

The drug dilution sequence for Moxifloxacin printed on the panel is incorrect. As a result, incorrect MIC results for Mxf could be reported.

Details

Recalling Firm
Beckman Coulter Inc.
Units Affected
686 boxes
Distribution
NJ, TX, IA, PA, FL, NE, OH, NY, CA, MO, OK, LA
Location
Brea, CA

Frequently Asked Questions

What product was recalled?
MicroScan Pos Combo Panel Type 43, Catalog number B1017-217for use in determining antimicrobial agent susceptibility and/or identification to the species level of rapidly growing aerobic and facultative gram-positive cocci, some fastidious aerobic gram-positive cocci and Listeria monocytogenes.. Recalled by Beckman Coulter Inc.. Units affected: 686 boxes.
Why was this product recalled?
The drug dilution sequence for Moxifloxacin printed on the panel is incorrect. As a result, incorrect MIC results for Mxf could be reported.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 8, 2018. Severity: Moderate. Recall number: Z-2599-2018.